Markets

First Light Asset Management, LLC Buys Immunomedics, NeoGenomics, Shire PLC, Sells BioScrip, ...

First Light Asset Management, LLC

  • New Purchases: IBB , MGNX , XLV , IHI, IRMD, ABBV,
  • Added Positions:IMMU, NEO, SHPG, TECH, CELG, VCYT, OXFD, HSTM, BLUE, AMED,
  • Reduced Positions:PETX, LMAT, TLGT, RTIX, STRM, SPNC, AVGR, HBIO, NVS, ENZ,
  • Sold Out:BIOS, OFIX, CYNA, ELGX, CPHD, BEAT, BDX, AGN, STE, LLY,

For the details of First Light Asset Management, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=First+Light+Asset+Management%2C+LLC

These are the top 5 holdings of First Light Asset Management, LLC

  1. NeoGenomics Inc ( NEO ) - 2,573,891 shares, 9.78% of the total portfolio. Shares added by 26.63%
  2. AtriCure Inc ( ATRC ) - 939,012 shares, 8.15% of the total portfolio. Shares added by 0.98%
  3. Akorn Inc ( AKRX ) - 534,524 shares, 5.17% of the total portfolio. Shares added by 1.71%
  4. Oxford Immunotec Global PLC ( OXFD ) - 747,639 shares, 4.96% of the total portfolio. Shares added by 3.28%
  5. LHC Group Inc ( LHCG ) - 219,992 shares, 4.46% of the total portfolio. Shares reduced by 1.35%

New Purchase: iShares Nasdaq Biotechnology Index Fund (IBB)

First Light Asset Management, LLC initiated holdings in iShares Nasdaq Biotechnology Index Fund. The purchase prices were between $246.87 and $293.09, with an estimated average price of $273.18. The stock is now traded at around $292.98. The impact to the portfolio due to this purchase was 0.93%. The holdings were 7,897 shares as of 2016-12-31.

New Purchase: Macrogenics Inc (MGNX)

First Light Asset Management, LLC initiated holdings in Macrogenics Inc. The purchase prices were between $18.36 and $30.95, with an estimated average price of $25.17. The stock is now traded at around $21.09. The impact to the portfolio due to this purchase was 0.56%. The holdings were 61,835 shares as of 2016-12-31.

New Purchase: SPDR Select Sector Fund - Health Care (XLV)

First Light Asset Management, LLC initiated holdings in SPDR Select Sector Fund - Health Care. The purchase prices were between $66.02 and $72.2, with an estimated average price of $69.42. The stock is now traded at around $73.56. The impact to the portfolio due to this purchase was 0.56%. The holdings were 18,241 shares as of 2016-12-31.

New Purchase: iShares U.S. Medical Devices (IHI)

First Light Asset Management, LLC initiated holdings in iShares U.S. Medical Devices. The purchase prices were between $129.43 and $146.43, with an estimated average price of $136.12. The stock is now traded at around $146.92. The impact to the portfolio due to this purchase was 0.45%. The holdings were 7,580 shares as of 2016-12-31.

New Purchase: iRadimed Corp (IRMD)

First Light Asset Management, LLC initiated holdings in iRadimed Corp. The purchase prices were between $9.05 and $17.01, with an estimated average price of $10.77. The stock is now traded at around $8.50. The impact to the portfolio due to this purchase was 0.19%. The holdings were 39,355 shares as of 2016-12-31.

New Purchase: AbbVie Inc (ABBV)

First Light Asset Management, LLC initiated holdings in AbbVie Inc. The purchase prices were between $55.78 and $64, with an estimated average price of $61.04. The stock is now traded at around $61.48. The impact to the portfolio due to this purchase was 0.12%. The holdings were 4,159 shares as of 2016-12-31.

Added: Immunomedics Inc (IMMU)

First Light Asset Management, LLC added to the holdings in Immunomedics Inc by 129.84%. The purchase prices were between $2.11 and $4.03, with an estimated average price of $2.96. The stock is now traded at around $5.12. The impact to the portfolio due to this purchase was 2.1%. The holdings were 2,282,009 shares as of 2016-12-31.

Added: NeoGenomics Inc ( NEO )

First Light Asset Management, LLC added to the holdings in NeoGenomics Inc by 26.63%. The purchase prices were between $7.13 and $9.79, with an estimated average price of $8.57. The stock is now traded at around $8.15. The impact to the portfolio due to this purchase was 2.06%. The holdings were 2,573,891 shares as of 2016-12-31.

Added: Shire PLC (SHPG)

First Light Asset Management, LLC added to the holdings in Shire PLC by 90.06%. The purchase prices were between $163.77 and $197.7, with an estimated average price of $177.25. The stock is now traded at around $178.70. The impact to the portfolio due to this purchase was 1.33%. The holdings were 37,248 shares as of 2016-12-31.

Added: Bio-Techne Corp (TECH)

First Light Asset Management, LLC added to the holdings in Bio-Techne Corp by 62.20%. The purchase prices were between $99.28 and $111.17, with an estimated average price of $105.09. The stock is now traded at around $105.01. The impact to the portfolio due to this purchase was 0.67%. The holdings were 38,502 shares as of 2016-12-31.

Added: Celgene Corp (CELG)

First Light Asset Management, LLC added to the holdings in Celgene Corp by 222.36%. The purchase prices were between $97.63 and $124.16, with an estimated average price of $111.36. The stock is now traded at around $118.66. The impact to the portfolio due to this purchase was 0.49%. The holdings were 13,797 shares as of 2016-12-31.

Added: Veracyte Inc (VCYT)

First Light Asset Management, LLC added to the holdings in Veracyte Inc by 20.64%. The purchase prices were between $6.12 and $8.14, with an estimated average price of $7.48. The stock is now traded at around $7.73. The impact to the portfolio due to this purchase was 0.41%. The holdings were 692,210 shares as of 2016-12-31.

Sold Out: BioScrip Inc (BIOS)

First Light Asset Management, LLC sold out the holdings in BioScrip Inc. The sale prices were between $1.02 and $3.33, with an estimated average price of $1.92.

Sold Out: Orthofix International NV (OFIX)

First Light Asset Management, LLC sold out the holdings in Orthofix International NV. The sale prices were between $34.56 and $42.01, with an estimated average price of $37.96.

Sold Out: Cynapsus Therapeutics Inc (CYNA)

First Light Asset Management, LLC sold out the holdings in Cynapsus Therapeutics Inc. The sale prices were between $40.21 and $40.48, with an estimated average price of $40.39.

Sold Out: Endologix Inc (ELGX)

First Light Asset Management, LLC sold out the holdings in Endologix Inc. The sale prices were between $5.27 and $13.21, with an estimated average price of $9.16.

Sold Out: Cepheid (CPHD)

First Light Asset Management, LLC sold out the holdings in Cepheid. The sale prices were between $52.62 and $52.95, with an estimated average price of $52.81.

Sold Out: BioTelemetry Inc (BEAT)

First Light Asset Management, LLC sold out the holdings in BioTelemetry Inc. The sale prices were between $15.35 and $23.35, with an estimated average price of $19.55.

Premium Members

This article first appeared on GuruFocus .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

LHCG NEO OXFD ATRC

Other Topics

Stocks

Latest Markets Videos